Kaixuan Zeng

5.0k total citations · 2 hit papers
44 papers, 2.9k citations indexed

About

Kaixuan Zeng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kaixuan Zeng has authored 44 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 28 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Kaixuan Zeng's work include Circular RNAs in diseases (23 papers), Cancer-related molecular mechanisms research (19 papers) and MicroRNA in disease regulation (18 papers). Kaixuan Zeng is often cited by papers focused on Circular RNAs in diseases (23 papers), Cancer-related molecular mechanisms research (19 papers) and MicroRNA in disease regulation (18 papers). Kaixuan Zeng collaborates with scholars based in China, Bangladesh and Canada. Kaixuan Zeng's co-authors include Shukui Wang, Xiangxiang Liu, Xiaoxiang Chen, Yuqin Pan, Mu Xu, Huiling Sun, Bangshun He, Bei Pan, Xueni Xu and Tao Xu and has published in prestigious journals such as Circulation Research, Oncogene and Cell Death and Differentiation.

In The Last Decade

Kaixuan Zeng

41 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer

2020 280 citations Xiaoxiang Chen, Mu Xu et al. Molecular Cancer profile →
Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer

2023 93 citations Kaixuan Zeng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kaixuan Zeng China	27	2.5k	2.2k	266	263	143	44	2.9k
Mu Xu China	21	2.1k 0.9×	2.0k 0.9×	191 0.7×	235 0.9×	140 1.0×	39	2.5k
Youtao Xu China	21	1.6k 0.6×	1.4k 0.7×	294 1.1×	249 0.9×	79 0.6×	43	2.0k
Zhenqiang Sun China	19	1.7k 0.7×	1.5k 0.7×	390 1.5×	354 1.3×	121 0.8×	42	2.3k
Xueni Xu China	14	1.4k 0.6×	1.3k 0.6×	129 0.5×	137 0.5×	109 0.8×	20	1.6k
Haiou Yang China	18	2.0k 0.8×	1.6k 0.7×	516 1.9×	274 1.0×	63 0.4×	32	2.4k
Ryunosuke Kogo Japan	14	1.6k 0.7×	1.7k 0.7×	95 0.4×	242 0.9×	145 1.0×	38	2.1k
Bo Shen China	23	1.2k 0.5×	956 0.4×	189 0.7×	314 1.2×	72 0.5×	73	1.6k
Shujuan Ni China	24	2.2k 0.9×	2.1k 0.9×	309 1.2×	550 2.1×	164 1.1×	61	2.9k
Dingzhi Huang China	21	1.4k 0.6×	1.2k 0.5×	364 1.4×	499 1.9×	102 0.7×	76	2.0k

Countries citing papers authored by Kaixuan Zeng

Since Specialization

Citations

This map shows the geographic impact of Kaixuan Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaixuan Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaixuan Zeng more than expected).

Fields of papers citing papers by Kaixuan Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaixuan Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaixuan Zeng. The network helps show where Kaixuan Zeng may publish in the future.

Co-authorship network of co-authors of Kaixuan Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Kaixuan Zeng. A scholar is included among the top collaborators of Kaixuan Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaixuan Zeng. Kaixuan Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tao, Yiran, et al.. (2025). Matrix stiffness maintains bladder cancer stemness via integrin-nuclear skeleton axis. Cell Death and Disease. 16(1). 887–887.

Nie, Z. D., Z. Q. Yang, Kaixuan Zeng, et al.. (2025). PRMT5 highly expressed on CD16 + CD56- natural killer cells is correlated with NK cells exhaustion in colorectal cancer mesenchyme. Cancer Immunology Immunotherapy. 74(4). 139–139.

Huang, Jiayu, Huan Yang, Kaixuan Zeng, et al.. (2025). High matrix stiffness triggers testosterone decline in aging males by disrupting stem Leydig cell pool homeostasis. Cell Reports. 44(9). 116207–116207. 1 indexed citations

Zeng, Kaixuan, Na Huang, Nanbin Liu, et al.. (2024). LACTB suppresses liver cancer progression through regulation of ferroptosis. Redox Biology. 75. 103270–103270. 11 indexed citations

Wang, Shengting, Yufang Wang, Yue Wang, et al.. (2023). Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism. Discover Oncology. 14(1). 67–67. 9 indexed citations

Wang, Shengting, Yufang Wang, Qian Li, et al.. (2023). RUNX1-IT1 favors breast cancer carcinogenesis through regulation of IGF2BP1/GPX4 axis. Discover Oncology. 14(1). 42–42. 26 indexed citations

Wu, Nan, Feiya Li, Weining Yang, et al.. (2022). Silencing mouse circular RNA circSlc8a1 by circular antisense cA-circSlc8a1 induces cardiac hepatopathy. Molecular Therapy. 31(6). 1688–1704. 19 indexed citations

Zeng, Kaixuan, Xiaoxiang Chen, Xiuxiu Hu, et al.. (2021). Correction: LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation. Oncogene. 40(21). 3772–3773. 2 indexed citations

Li, Chenmeng, Bei Pan, Xiangxiang Liu, et al.. (2021). Long intergenic non-coding RNA LINC00485 exerts tumor-suppressive activity by regulating miR-581/EDEM1 axis in colorectal cancer. Aging. 13(3). 3866–3885. 9 indexed citations

10.

Ma, Jian, William W. Du, Kaixuan Zeng, et al.. (2021). An antisense circular RNA circSCRIB enhances cancer progression by suppressing parental gene splicing and translation. Molecular Therapy. 29(9). 2754–2768. 45 indexed citations

11.

Wu, Nan, Jindong Xu, William W. Du, et al.. (2020). YAP Circular RNA, circYap, Attenuates Cardiac Fibrosis via Binding with Tropomyosin-4 and Gamma-Actin Decreasing Actin Polymerization. Molecular Therapy. 29(3). 1138–1150. 78 indexed citations

12.

Chen, Xiaoxiang, Mu Xu, Xueni Xu, et al.. (2020). METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Molecular Cancer. 19(1). 106–106. 280 indexed citations breakdown →

13.

Xu, Mu, Xueni Xu, Bei Pan, et al.. (2019). LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Molecular Cancer. 18(1). 135–135. 206 indexed citations

14.

Xu, Mu, Xiaoxiang Chen, Lin Kang, et al.. (2019). lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer. Journal of Hematology & Oncology. 12(1). 3–3. 161 indexed citations

15.

Chen, Xiaoxiang, Kaixuan Zeng, Mu Xu, et al.. (2019). P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2. Cell Death and Disease. 10(2). 131–131. 82 indexed citations

16.

Chen, Xiaoxiang, Kaixuan Zeng, Mu Xu, et al.. (2018). SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis. Cell Death and Disease. 9(10). 982–982. 172 indexed citations

17.

Zeng, Kaixuan, Bangshun He, Burton B. Yang, et al.. (2018). The pro-metastasis effect of circANKS1B in breast cancer. Molecular Cancer. 17(1). 160–160. 237 indexed citations

18.

Zeng, Kaixuan, Xiaoxiang Chen, Xiuxiu Hu, et al.. (2018). LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation. Oncogene. 37(41). 5534–5551. 72 indexed citations

19.

Liu, Yang, Mingyang Li, Kaixuan Zeng, et al.. (2017). EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features. Human Pathology. 64. 213–221. 20 indexed citations

20.

Zeng, Kaixuan, Zhe Wang, Koichi Ohshima, et al.. (2016). BRAFV600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis. OncoImmunology. 5(7). e1185582–e1185582. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact